Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in NRXP held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | B Group, Inc. | 3.0M | $6.4M | β | 17.355% | 4.74% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $2.5M | β | 6.712% | 0.00% |
| 3 | AdvisorShares Investments LLC | 420K | $896K | +28.2% | 2.433% | 0.16% |
| 4 | COMMONWEALTH EQUITY SERVICES, LLC | 397K | $847K | +8.4% | 2.299% | 0.00% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 310K | $661K | +41.7% | 1.794% | 0.00% |
| 6 | VANGUARD FIDUCIARY TRUST CO | 170K | $361K | β | 0.981% | 0.00% |
| 7 | Bleakley Financial Group, LLC | 117K | $250K | 0.0% | 0.678% | 0.00% |
| 8 | BlackRock, Inc. | 99K | $211K | +19.8% | 0.573% | 0.00% |
| 9 | STATE STREET CORP | 87K | $185K | 0.0% | 0.503% | 0.00% |
| 10 | XTX Topco Ltd | 79K | $168K | β | 0.456% | 0.00% |
| 11 | NORTHERN TRUST CORP | 43K | $93K | +50.2% | 0.252% | 0.00% |
| 12 | Headlands Technologies LLC | 39K | $84K | β | 0.228% | 0.01% |
| 13 | AXQ CAPITAL, LP | 33K | $71K | β | 0.192% | 0.01% |
| 14 | UBS Group AG | 25K | $54K | +613.0% | 0.146% | 0.00% |
| 15 | Schonfeld Strategic Advisors LLC | 20K | $42K | β | 0.115% | 0.00% |
| 16 | Ethos Financial Group, LLC | 16K | $34K | +33.6% | 0.092% | 0.00% |
| 17 | SJBENEN ADVISORY, LLC | 15K | $32K | 0.0% | 0.087% | 0.03% |
| 18 | National Philanthropic Trust | 10K | $25K | β | 0.058% | 0.00% |
| 19 | MORGAN STANLEY | 10K | $21K | -0.0% | 0.058% | 0.00% |
| 20 | SBI Securities Co., Ltd. | 3K | $5K | 0.0% | 0.015% | 0.00% |
| 21 | WELLS FARGO & COMPANY/MN | 2K | $5K | +17.5% | 0.014% | 0.00% |
| 22 | ROYAL BANK OF CANADA | 3K | $5K | +25.4% | 0.015% | 0.00% |
| 23 | CLEAR STREET MARKETS LLC | 1K | $2K | β | 0.007% | 0.00% |
| 24 | GROUP ONE TRADING, L.P. | 737 | $2K | β | 0.004% | 0.00% |
| 25 | ADVISOR GROUP HOLDINGS, INC. | 90 | $191 | 0.0% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in NRXP β a direct measure of their conviction.
Filings activity in NRXP during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new NRXP position in Q1 2026
Institutions that fully closed their NRXP position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 30 | +11% | 19.45% | 1.74 pp | $13M | 8.2% |
| Q4 2025 | 27 | +13% | 21.19% | +1.48 pp | $14M | +7.5% |
| Q3 2025 | 24 | 7.7% | 19.71% | +5.01 pp | $13M | +34% |
| Q2 2025 | 26 | +13% | 14.70% | +7.77 pp | $10M | +112% |
| Q1 2025 | 23 | 4.2% | 6.93% | +3.46 pp | $5M | +100% |
| Q4 2024 | 24 | +26% | 3.47% | +1.65 pp | $2M | +91% |
| Q3 2024 | 19 | +0.0% | 1.82% | 0.02 pp | $1M | 1.0% |
| Q2 2024 | 19 | β | 1.84% | β | $1M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying NRXP stock.
Based on Q1 2026 13F filings, institutional ownership of NRx Pharmaceuticals, Inc. stands at 19.4%, held across 30 reporting institutions.
B Group, Inc. is the largest reported institutional holder of NRXP, with approximately 3,000,000 shares worth $0.01B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of NRXP.
Our composite Smart Money Score for NRXP is 29 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
12 institutions opened new positions in NRXP during Q1 2026, while 9 fully exited. 6 added to existing positions and 11 trimmed.
NRXP institutional ownership fell by 1.74 percentage points quarter-over-quarter, with a net change of +3 holders.
The top 10 institutions account for 96.3% of all reported 13F value in NRXP, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
NRx Pharmaceuticals, Inc. (NRXP) Institutional Ownership